GlassScriptPhysician profile
Lakendra Wiley
NPI 1588291785
$833.52
in general payments reported to CMS, 2019-2025
12 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.52 · 2022: $214 · 2023: $288 · 2024: $82.31 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525 · Travel and Lodging: $32.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.66 |
| Travel and Lodging | $32.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $167.74 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $162.23 | 2022-2023 | Andexxa |
| Baxter Healthcare | $121.31 | 2021-2025 | Floseal |
| Alexion Pharmaceuticals, INC. | $114.51 | 2021-2024 | Ultomiris |
| Sk Life Science, INC. | $61.96 | 2023 | |
| Eisai INC. | $54.10 | 2023-2024 | |
| Djo, LLC | $49.90 | 2023 | Cmf |
| Jazz Pharmaceuticals INC. | $23.04 | 2024 | |
| Acorda Therapeutics, INC | $22.48 | 2022 | |
| Kls-Martin L.P. | $19.02 | 2021 | |
| Argenx US, INC. | $18.80 | 2023 | Vyvgart |
| Amgen INC. | $18.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lakendra Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.